Search - tctmd.com

Displaying 41 - 60 of 395

Sort: Relevancy | Date

News Conference News TCT 2024

Colchicine Surprise: No Help Post-MI, Large CLEAR SYNERGY Trial Shows

Michael O'Riordan

October 29, 2024

News Daily News

CVD Risk Twofold Higher in Patients With Cancer: ASPREE

Michael O'Riordan

September 27, 2024

News Daily News

Statins Are Cost-effective in the Elderly

Michael O'Riordan

September 11, 2024

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for August 2024

Caitlin E. Cox

September 03, 2024

News Conference News ESC 2024

Getting to Cholesterol Goal Early After MI Lowers Risk of Recurrent Events

Michael O'Riordan

September 01, 2024

News Conference News ESC 2024

NOTION-3: PCI Before TAVI Lowers MACE Risks in Patients With Significant CAD

Michael O'Riordan

September 01, 2024

News Conference News SCCT 2024

Should Coronary Calcium Always Be Noted on Noncardiac CT Reports?

Todd Neale

July 24, 2024

News Daily News

Aligning Pill Burden and Palliative Care Needs in Late-Stage CVD: AHA

L.A. McKeown

July 02, 2024

News Daily News

ORBITA-STAR Highlights Variability in Symptom Changes Post-PCI

Michael O'Riordan

July 01, 2024

News Daily News

Think You Need a Statin? AHA’s Risk Calculator May Disagree

Michael O'Riordan

June 28, 2024

News Daily News

Burden of CVD Still High in UK Despite Prevention Efforts Over 20 Years

Yael L. Maxwell

June 26, 2024

News Daily News

AHA Celebrates a Century by Looking Back, and Forward

Shelley Wood

June 10, 2024

News Daily News

Excess ApoB Linked to Increased MI, ASCVD Risk in Adults

Michael O'Riordan

June 04, 2024

News Daily News

Lp(a) Linked to Higher ASCVD Risks in Diverse Patient Groups

Michael O'Riordan

April 17, 2024

News Conference News ACC 2024

Need a Statin for Primary Prevention? There’s an App for That

Michael O'Riordan

April 10, 2024

News Conference News ACC 2024

Another Beta-blocker Blow: REDUCE-AMI Confirms No Benefit After Acute MI

Michael O'Riordan

April 07, 2024

News Daily News

Invasive Angio Adds Nothing to CCTA Alone for Risk Prediction: ISCHEMIA

Michael O'Riordan

March 14, 2024

News Daily News

AEGIS-II Misses Primary Endpoint, Dealing New Blow to HDL Hypothesis

Todd Neale

February 14, 2024

News Daily News

Evolocumab Reduces MACE in Patients With and Without Multivessel CAD: FOURIER

Michael O'Riordan

February 08, 2024

News Daily News

Obstructive CAD Can Be Left Alone Before TAVI, Observational Data Suggest

Michael O'Riordan

January 30, 2024

Advertisement

Colchicine Surprise: No Help Post-MI, Large CLEAR SYNERGY Trial Shows

CVD Risk Twofold Higher in Patients With Cancer: ASPREE

Statins Are Cost-effective in the Elderly

TCTMD’s Top 10 Most Popular Stories for August 2024

Getting to Cholesterol Goal Early After MI Lowers Risk of Recurrent Events

NOTION-3: PCI Before TAVI Lowers MACE Risks in Patients With Significant CAD

Should Coronary Calcium Always Be Noted on Noncardiac CT Reports?

Aligning Pill Burden and Palliative Care Needs in Late-Stage CVD: AHA

ORBITA-STAR Highlights Variability in Symptom Changes Post-PCI

Think You Need a Statin? AHA’s Risk Calculator May Disagree

Burden of CVD Still High in UK Despite Prevention Efforts Over 20 Years

AHA Celebrates a Century by Looking Back, and Forward

Excess ApoB Linked to Increased MI, ASCVD Risk in Adults

Lp(a) Linked to Higher ASCVD Risks in Diverse Patient Groups

Need a Statin for Primary Prevention? There’s an App for That

Another Beta-blocker Blow: REDUCE-AMI Confirms No Benefit After Acute MI

Invasive Angio Adds Nothing to CCTA Alone for Risk Prediction: ISCHEMIA

AEGIS-II Misses Primary Endpoint, Dealing New Blow to HDL Hypothesis

Evolocumab Reduces MACE in Patients With and Without Multivessel CAD: FOURIER

Obstructive CAD Can Be Left Alone Before TAVI, Observational Data Suggest

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content